Product Overview

Clomiphene 25 mg is a generic pharmaceutical formulation that contains the selective estrogen receptor modulator clomiphene citrate as the active ingredient. Manufactured by Serum Institute India, this medication is indicated for the treatment of female infertility associated with ovulatory dysfunction. The product is supplied in a strip containing five tablets, each delivering a precise dose of 25 mg clomiphene. Pack sizes are available in 30, 60, or 90 tablets, allowing patients and clinicians to select the most appropriate quantity for a prescribed treatment cycle. Clomiphene citrate has been widely studied and is listed on authoritative medical databases such as the NIH’s National Library of Medicine and the FDA’s drug database, confirming its safety profile when used under professional supervision.

What is Clomiphene 25 mg

Clomiphene citrate is a well‑characterized non‑steroidal compound that acts as a partial agonist/antagonist at estrogen receptors in the hypothalamus and pituitary gland. By modulating estrogen signaling, it stimulates the release of gonadotropin‑releasing hormone (GnRH), which in turn increases the secretion of follicle‑stimulating hormone (FSH) and luteinizing hormone (LH). This hormonal surge promotes the development and maturation of ovarian follicles, making it a cornerstone therapy for women who experience irregular or absent ovulation.

First synthesized in the 1960s, clomiphene quickly became a standard oral agent for ovulation induction. Its long‑standing use is documented in numerous clinical trials indexed on PubMed and referenced by the World Health Organization. The medication is classified under the category of female infertility treatments and is often prescribed alongside lifestyle modifications or other assisted reproductive techniques.

Uses and Benefits

• Induction of ovulation in women with polycystic ovary syndrome (PCOS) or unexplained anovulation.
• Facilitates timed intercourse or intrauterine insemination (IUI) cycles.
• Oral administration simplifies dosing compared with injectable gonadotropins.
• Well‑studied safety profile when used according to clinical guidelines.
• Available in multiple pack sizes to match individualized treatment plans.

When combined with proper monitoring, clomiphene can increase the chance of pregnancy per cycle by up to 10‑15 percent in appropriate patient populations. Its low cost and oral route make it an accessible first‑line option for many clinicians.

How It Works

The mechanism of action of clomiphene involves competitive binding to estrogen receptors in the hypothalamic region. This blockade creates a perception of low endogenous estrogen levels, prompting the pituitary gland to increase the synthesis and release of FSH and LH. The rise in these gonadotropins stimulates the growth of multiple ovarian follicles, which may mature and release an oocyte during the ensuing luteal phase. The dual agonist/antagonist activity of clomiphene allows it to produce a predictable ovulatory response while minimizing the risk of excessive estrogenic stimulation.

Pharmacokinetic studies show that clomiphene is well absorbed after oral administration, reaching peak plasma concentrations within a few hours. The drug undergoes hepatic metabolism and is eliminated primarily through biliary excretion. Its metabolite, norclomiphene, contributes to the overall anti‑estrogenic effect and is detectable in urine for several weeks after the last dose.

Dosage Guidelines

Clomiphene should only be prescribed after a thorough clinical evaluation by a qualified healthcare professional. Typical regimens involve a daily oral dose of 25 mg for five consecutive days, usually initiated on the third to fifth day of the menstrual cycle. The exact day of initiation and the number of cycles may vary based on individual patient response, ovarian reserve testing, and the treating physician’s protocol. If ovulation does not occur after three cycles, alternative or adjunctive treatments should be considered.

It is essential that patients do not self‑administer higher doses or extend treatment beyond the recommended duration without medical oversight. Overuse can increase the risk of ovarian hyperstimulation and multiple pregnancies. Always follow the prescribing clinician’s instructions and discuss any questions or concerns before adjusting the regimen.

Side Effects

Most adverse reactions to clomiphene are mild and transient. Commonly reported side effects include hot flashes, abdominal discomfort, breast tenderness, and occasional visual disturbances such as blurred vision. Less frequent effects may involve nausea, headache, or ovarian cyst formation, which typically resolve spontaneously. Rare but serious complications can include ovarian hyperstimulation syndrome (OHSS), thromboembolic events, and visual disturbances that persist after discontinuation. Patients experiencing severe abdominal pain, rapid weight gain, or shortness of breath should seek immediate medical attention.

Long‑term use of clomiphene has not been associated with an increased risk of breast or ovarian cancer in current research, but ongoing surveillance is recommended. For a comprehensive list of side effects, refer to the FDA drug label or consult a pharmacist.

Warnings and Precautions

Clomiphene is contraindicated in individuals with known hypersensitivity to the drug, active liver disease, or those who are pregnant or breastfeeding. Prior to initiation, clinicians should assess ovarian function, hormonal profiles, and uterine health. Patients with a history of thromboembolic disorders, abnormal uterine bleeding, or ovarian cysts larger than 3 cm should be evaluated carefully.

Interaction with certain medications, such as steroids or other hormonal agents, may alter the therapeutic response. It is important to disclose all prescription, over‑the‑counter, and herbal products to the prescribing clinician. Regular monitoring through ultrasound or hormonal assays is recommended to track follicular development and adjust dosing as needed.

For additional regulatory information, consult the FDA and NIH resources.

FAQs

What is Clomiphene 25 mg used for?

Clomiphene 25 mg is used to stimulate ovulation in women who have difficulty conceiving due to ovulatory dysfunction, such as PCOS or unexplained infertility.

How should I take Clomiphene 25 mg?

The medication is typically taken as one tablet daily for five consecutive days, starting on a specific day of the menstrual cycle as directed by a healthcare provider.

Are there any serious side effects?

Rare but serious side effects include ovarian hyperstimulation syndrome, visual disturbances, and thromboembolic events. Seek immediate medical attention if you experience severe abdominal pain, shortness of breath, or sudden vision changes.

Can I use Clomiphene if I have PCOS?

Yes, clomiphene is commonly prescribed for women with PCOS to induce ovulation, but it should only be used under medical supervision and with appropriate monitoring.

Where can I find more information about Clomiphene?

Detailed prescribing information is available from the Drugs.com database, and comprehensive medical references can be found on MedlinePlus and Wikipedia.

Conclusion

Clomiphene 25 mg offers an evidence‑based, cost‑effective option for women seeking to overcome ovulatory infertility. Its well‑documented mechanism, established safety profile, and availability in multiple pack sizes make it a reliable choice for clinicians and patients alike. Always consult a qualified healthcare professional before starting or modifying treatment to ensure optimal outcomes and minimize risks.

Related Products

• CB-Lin (Cabergoline)
• Meprate 10 mg (Medroxyprogesterone)
• Sicriptin 2.5 mg Tablets (Bromocriptine)
• Sicriptin 1.25 mg Tablets (Bromocriptine)
• Sicriptin (Bromocriptine)
• Bromocriptine 1.25 mg (Generic)
• Bromocriptine 2.5 mg (Generic)
• ZyhCG 10000 (HCG 10000iu)
• ZyhCG 5000 (HCG 5000iu)
• ZyhCG 2000 (HCG 2000iu)
• Sifasi Aqua 5000 (HCG (Human Chorionic Gonadotropin))
• Clomiphene 50 mg (Generic)